Open Access
14.02.2026 | Research
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study
Zehra Sucuoğlu İşleyen, Şaban Seçmeler, Abdullah Sakin, Şener Cihan, Mehmet Beşiroğlu, Seda Kahraman, Melek Karakurt Eryılmaz, Esra Zeynelgil, Eda Çalışkan Yıldırım, Engin Kut, Nilay Şengül, Fatma Paksoy Türköz, Özkan Alan, Özlem Özkul, Selver Işık, Feride Yılmaz, Ahmet Gülmez, Sema Türker, Gökhan Karakaya, Meral Günaldı, Leyla Özer, Asude Aksoy, Fatih Karataş, Teoman Sakalar, Derya Demirtaş Esmer, Fatih Teker, Necla Demir, Özgecan Dülgar, Serdar Turhal, Hacı Mehmet Türk, Kayhan Ertürk, Emir Çelik, M. Mustafa Atcı
Open Access
13.02.2026 | Research
Deciphering the role of Ki67: prognostic insights in advanced breast cancer therapy with Cyclin-dependent kinase 4/6 inhibitors
Marcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna Świderska, Marta Mianowska-Malec, Aleksandra Leśniak, Barbarba Łanoszka, Konstanty Chomik, Barbara Grandys, Natalya Lisovska, Grzegorz Woźniak, Tomasz Latusek, Ewa Stobiecka, Jakub Simek, Bartłomiej Pyciński, Barbara Bobek-Billewicz, Ewa Chmielik, Michał Jarząb
Open Access
13.02.2026 | Research
Malnutrition-related symptom clusters and quality of life in nasopharyngeal carcinoma patients during radiotherapy: a network analysis
Meng-Yu Hao, Feng-Yan Li, Su-Man Zhang, Yu-Xian Yang, Yu-Xi Xiong, Hang-Yu Wang, Yao Zhuang Chuah, Zi-Hang Chen, Ling-Xin Xu, Peng Sun, Jian Ji, Lecheng Jia, Hua Li, Yanfei Liu, Ying Sun, Jia-Wei Lv, Yan Li, Guan-Qun Zhou
Open Access
13.02.2026 | Research
Association between four indirect indicators of insulin resistance and lung cancer: evidence from UK biobank and Mendelian randomization analysis
Yongze Dang, Xia Li, Yutong Cheng, Shupei Pan, Guoliang Li, Xiaoxiao Liu, Yuchen Wang, Xinyu He, Shangyi Geng, Hongbing Ma, Jingkun Qu, Xixi Zhao
Open Access
13.02.2026 | Research
Optimizing chemotherapy regimens and dosing for older patients with metastatic pancreatic cancer: insights from the Tokushukai real-world data project
Sakue Masuda, Yoshinori Imamura, Rai Shimoyama, Kiyoaki Uryu, Takahiro Mase, Masataka Taguri, Tadahisa Okuda, Megumi Shiragami, Yoshiaki Fujimura, Maki Hayashi, Hironobu Minami
Open Access
12.02.2026 | Research
Pretreatment clinical and hematological predictors of efficacy and immune-related adverse events in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immune checkpoint inhibitors
Shun Matsuura, Kensuke Kita, Kyohei Matsushita, Takumi Nagasaki, Ryo Suzuki, Yuya Yamamoto, Kotaro Yamada, Ryuuichi Nakamura, Norimichi Akiyama, Kazuki Tanaka, Naoki Koshimizu